Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies
By M. Seaman, H. Janes, Natalie R. Hawkins, L. E. Grandpre, C. Devoy, A. Giri, R. Coffey, Linda J. Harris, B. Wood, M. Daniels and 9 more. Journal of Virology, 2009
670 citations recorded by the source corpus.
Subfields: Hepatology, Infectious Diseases, Virology
View Paper: https://www.semanticscholar.org/paper/9eef41ea1e52b0ecf592ce40435eea01640dafe6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
Citations in the corpus
- Molecular Evolution of Broadly Neutralizing Llama Antibodies to the CD4-Binding Site of HIV-1 (2014, background): “While the potency of these responses is modest, the breadth of activity included ‘difficult-to–neutralize’ strains (categorized as tier 2, where tier 1 is easiest and tier 3 is most difficult to neutralize) [30] from clades A and C, and titers of.”
- HIV-1 envelope trimer fusion proteins and their applications (2016, positive): “130 We used the TZM-bl cell neutralization assay and viruses from different clades to assess the serum NAb titers 2 weeks after the protein boost in rabbits [19].”